Skip to main content
Clinical Trials/ACTRN12610001076066
ACTRN12610001076066
Completed
未知

A pilot study to evaluate tolerance, safety and efficacy of repeated prostate biopsy in patients undergoing high dose rate brachytherapy for prostate cancer

Peter MacCallum Cancer Centre0 sites13 target enrollmentDecember 7, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Peter MacCallum Cancer Centre
Enrollment
13
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Peter MacCallum Cancer Centre

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing high dose rate brachytherapy for prostate cancer

Exclusion Criteria

  • previous transurethral resection of prostate (TURP), anticoagulation, previous sepsis from prostate biopsy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A preliminary study to examine and evaluate the effect of obeticholic acid (INT-747) for the treatment of portal hypertension in patients with alcoholic liver disease
ISRCTN22662520Intercept Pharmaceuticals Inc34
Active, not recruiting
Phase 1
A pilot study to assess the safety, tolerability, dose finding and efficacy of ORY-1001 in combination with azacitidine in older patients with AML in first line therapy.Patients with acute mieloyd leukemia (AML)MedDRA version: 20.1Level: LLTClassification code 10024349Term: Leukemia myeloidSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2018-000482-36-ESOryzon Genomics S. A.30
Active, not recruiting
Phase 1
Study to assess the safety, tolerability, dose finding and efficacy ORY-1001 in combination with platinum-etoposide chemotherapy in patients with relapsed, extensive-stage disease small cell lung cancer
EUCTR2018-000469-35-ESOryzon Genomics S. A.33
Recruiting
Phase 1
Study to evaluate safety and tolerability of a Traditional Chinese Herbal medicine combination AL” (Astragalus membranaceus and Ligustrum lucidum) in people with advanced cancer.CancerCancer - Any cancer
ACTRN12615001203549Concord Repatriation General Hospital25
Recruiting
Not Applicable
A pilot study to investigate warm and humidified carbon dioxide delivery to the surgical site in patients undergoing craniotomy.Intracranial tissue desiccationBrain aneurysmSurgery - Other surgeryNeurological - Other neurological disorders
ACTRN12622001264774Fisher and Paykel Healthcare pty ltd30